U.S. License Holder:
Accord BioPharma
Date of License:
aBLA accepted by FDA January-2024
Last Update:
July-08-2024
FDA-Approved Indications
DMB-3115 (ustekinumab) is not FDA-approved. An aBLA has been accepted by the FDA.